Organization | Bursa Yüksek İhtisas Education and Research Hospital

Bursa Yüksek İhtisas Education and Research Hospital Report issue

Academic/Hospital Phase 4

Founded: Ankara Turkey

Organization Overview

First Clinical Trial

2016

NCT03217292

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

Bursa Yüksek İhtisas Education and Research Hospital | University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospita

Active Ingredients

Drugs in Phase 4 Trials (2)

bupivacaine (Exparel) (3 trials)

methylprednisolone (medrol) (1 trial)

Drugs in Other Trials (6)

betamethasone (celestone) (1 trial)

morphine (2 trials)

ropivacaine (naropin) (1 trial)

sufentanil (1 trial)

tramadol (Ultram) (5 trials)

tranexamic acid (cyklokapron) (1 trial)

Indications

Overview

Highest Phase: Phase 4
# of Trials: 11
# of Trial APIs: 8